Cargando…
EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
Osteosarcoma (OS) is a rare tumor of the bone occurring mainly in young adults accounting for 5% of all childhood cancers. Because of the limited therapeutic options, there has been no survival improvement for OS patients in the past 40 years. The epidermal growth factor receptor (EGFR) is highly ex...
Autores principales: | Linder, Markus, Glitzner, Elisabeth, Srivatsa, Sriram, Bakiri, Latifa, Matsuoka, Kazuhiko, Shahrouzi, Parastoo, Dumanic, Monika, Novoszel, Philipp, Mohr, Thomas, Langer, Oliver, Wanek, Thomas, Mitterhauser, Markus, Wagner, Erwin F, Sibilia, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220323/ https://www.ncbi.nlm.nih.gov/pubmed/30361264 http://dx.doi.org/10.15252/emmm.201809408 |
Ejemplares similares
-
EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation
por: Linder, Markus, et al.
Publicado: (2018) -
RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015) -
Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis
por: Matsuoka, Kazuhiko, et al.
Publicado: (2023) -
Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020) -
Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells
por: Novoszel, Philipp, et al.
Publicado: (2021)